Primary Results of the AGO-Zervix-1 Study: A Prospective, Randomized Phase III Study to Compare the Effects of Paclitaxel and Topotecan with Those of Cisplatin and Topotecan in the Treatment of Patients with Recurrent and Persistent Cervical Cancer
Gynecologic Oncology(2024)
Key words
Recurrent,Metastatic,Cervical cancer,Topotecan,Paclitaxel,Cisplatin
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined